The largest database of trusted experimental protocols

Ilium xylazil 100

Manufactured by Troy Laboratories
Sourced in United Kingdom

Ilium Xylazil-100 is a laboratory equipment designed for the controlled administration of xylazine, a sedative and analgesic agent commonly used in veterinary medicine. The device provides precise dosing and monitoring capabilities for researchers and clinicians working with animal subjects.

Automatically generated - may contain errors

3 protocols using ilium xylazil 100

1

Intravitreal Administration of Epigenetic Modulators in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anesthetized with an intraperitoneal injection of 40 mg/kg Ketamine (Ceva Animal Health Pty Ltd, Amersham, UK) and 5 mg/kg Ilium Xylazil-100 (Troy Laboratories, New South Wales, Australia) or subcutaneously with a mixture of Ketamine (85 mg/kg; Parke-Davis, Berlin, Germany) and xylazine (4 mg/kg; Bayer AG, Leverkusen, Germany). Single intravitreal injections of 0.5 uL were administered at PN (Postnatal day) 14, with either 100 nM of Trichostatin A (TSA; Sigma) or 10 µM of GSK-J4 (Selleckchem, Texas, USA) administered in one eye and the contralateral eye receiving 0.0001% DMSO (diluted in 0.9% sodium chloride solution [Sigma]). GSK-J4 contained 0.0001% DMSO and was further diluted in 0.9% sodium chloride solution to make a 100 µM solution, while TSA (Trichostatin A) also contained 0.0001% DMSO with dilution to make a 100 nM solution. Assuming a 5 uL free vitreous volume [26 ], the final concentration of treatment was 10 nM TSA or 10 µM of GSK-J4. Anesthesia was reversed with Ilium Atipamezole (1 mg/kg; Troy Laboratories) or Antisedan (Atipamezole; 2 mg/kg; Orion Corp, Espoo, Finland).
+ Open protocol
+ Expand
2

Controlled Cortical Impactor TBI Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Traumatic brain injury was induced by a controlled cortical impactor (CCI) TBI 0310 (Precision Systems and Instrumentation, LLC, Fairfax, VA, USA). TBI induction was described in our previous study [11 (link)]. Briefly, mice were anesthetized by intraperitoneal injection of Zoletil 50 (tiletamine hydrochloride and zolazepam hydrochloride, 25 mg/ml/kg, VIRBAC Laboratories, Carros, France) and Ilium Xylazil-100 (Xylazine, 10 mg/ml/kg, Troy Laboratories, Australia) before surgery. After shaving and disinfection, the mouse skull underwent craniotomy at the left cortex using a drill. A 3 mm diameter impact head was settled 0.5 mm posterior to the bregma and 0.5 mm lateral to the midline. The weight drops a head on the flat exposed brain surface with 2 mm impact depth, 5 m/s impact velocity, and 500 ms dwell time. After cortical brain injury, the mouse skull was replaced, and the skin was enclosed with wound clips. The animals were returned to their home cage under a heat lamp until recovery from anesthesia.
+ Open protocol
+ Expand
3

Intravitreal Injection of Epigenetic Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anesthetized with an intraperitoneal injection of 40mg/kg Ketamine (Ceva Animal Health Pty Ltd, Amersham, UK) and 5mg/kg Ilium Xylazil-100 (Troy Laboratories, New South Wales, Australia) or subcutaneously with a mixture of ketamine (85mg/kg; Parke-Davis, Berlin, Germany) and xylazine (4mg/kg; Bayer AG, Leverkusen, Germany). Single intravitreal injections of 0.5uL were administered at PN14, with either 100nM of Trichostatin A (TSA; Sigma) or 10µM of GSK-J4 (Selleckchem, Texas, USA) administered in one eye and the contralateral eye receiving 0.0001% DMSO (diluted in 0.9% sodium chloride solution [Sigma]). GSK-J4 contained 0.0001% DMSO and was further diluted in 0.9% sodium chloride solution to make a 100µM solution, while TSA also contained 0.0001% DMSO with dilution to make a 100nM solution. Assuming a 5uL free vitreous volume [26] , the final concentration of treatment was 10nM TSA or 10µM of GSK-J4. Anesthesia was reversed with Ilium Atipamezole (1mg/kg; Troy Laboratories) or Antisedan (Atipamezole; 2mg/kg; Orion Corp, Espoo, Finland).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!